Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and welcome to PACBio's second quarter of 2026 earnings call. All participants will be in a listen only mode for the duration of the call. And should you need any assistance today, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. If you'd like to ask a question, you may press star one on your telephone keypad to join the queue. and to withdraw a question for any reason, please press star then two. Also, please be aware that today's call is being recorded. I'd now like to turn the call over to Kayleen Parrish from Gilmartin Group. Please go ahead. Good afternoon and welcome to PACBio's second quarter 2026 earnings conference call. With me today are Mark Van Oene, President and Chief Executive Officer, Jim Gibson, Chief Financial Officer and Christian Henry, PACBio board member and advisor. Earlier today, we issued a press release outlining the financial results we'll be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com or as furnished on Form 8K, available on the Securities and Exchange Commission website at www.sec.gov. A copy of our earnings presentation is also available on the Investors section of our website. On today's call, we will make forward-looking statements, including, among others, statements providing predictions, estimates, expectations, and guidance. You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks, and uncertainties that could cause our actual results to differ materially from those projected or discussed. Please review our SEC filings, including our most recent Form 10-Q and 10-K and our press releases, to bet...